secwatch.observer — SEC 8-K summary
======================================

Issuer:     Revolution Medicines, Inc. (RVMD)
CIK:        0001628171
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001193125-23-274137
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.01, 5.02, 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revolution Medicines completes acquisition of EQRx; exchange ratio 0.1112
-------------------------------------------------------------------------

- Acquisition closed Nov 9, 2023; EQRx stockholders received 0.1112 shares of RVMD common per EQRx share.
- EQRx common stock and warrants delisted from Nasdaq; EQRx ceases as separate public company.
- Sandra J. Horning appointed to RVMD board as EQRx designee, effective upon closing.
- Share issuance proposal approved by ~90% of votes cast at special meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628171/000119312523274137/0001193125-23-274137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628171/000119312523274137/d287738d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-274137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer